Skip to content
Contact Us
Webinar - On Demand

Effective Methods for Immune Monitoring in Autoimmune Trials

Date: October 1, 2021

Duration: 1 hour

Developing a therapeutic for an autoimmune indication can be challenging due to complex and often poorly understood disease biology. Effectively monitoring the state and types of cells present in the immune system is crucial to characterise and understand the inflammation processes central to autoimmune disease.
 
In this webinar, Sarah Harris Ph.D., Director of Translational Medicine at Bristol-Myers Squibb will present a case study on utilising multiple approaches for monitoring circulating leukocyte subsets to uncover keys to the mechanism-of-action of Ozanimod for Multiple Sclerosis.
 
Uli Hoffmueller, Ph.D., of Precision for Medicine, will share methods of immune monitoring for both peripheral blood and for tissue affected by autoimmune disease. In addition, he will outline criteria to guide selection of ideal clinical immune monitoring approaches.

Topics covered:
  • Case study on Ozanimod’s mechanism-of-action in Multiple Sclerosis.
     
  • Methods for immune monitoring in peripheral blood and affected tissue.
     
  • Criteria for selecting clinical immune monitoring approaches.

Register to Watch Webinar On Demand
Speakers

Uli Hoffmueller

Uli Hoffmueller PhD
Precision for Medicine

Veteran biochemist, industry expert, and cofounder of Epiontis. He holds a Master’s in Biochemistry from Humboldt University, a PhD from the Charité University Clinic, receiving the Charité Research Award, and an MBA from the Berlin School of Economics and Law, Berlin, Germany.

Sarah Harris

Sarah Harris
Bristol Myers Squibb

Highly accomplished translational medicine expert with 20 years of global experience in areas including preclinical though post-marketing TM strategy development and implementation, research and clinical TM program management, bioanalytical development, global regulatory filings, lab, site and P&L management and due diligence.